Publications
Surviving sepsis campaign : international guidelines for management of sepsis and septic shock 2021 Ghent University
Acute kidney injury in the biomarker area : results from a cohort of prospectively included patients with sepsis, severe sepsis or septic shock Ghent University
Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy. Vrije Universiteit Brussel
Objectives To review the most commonly reported underlying mechanisms of sepsis and septic shock, besides discussion of sepsis-induced cardiovascular dysfunction.
Therapeutic strategies for sepsis-induced myocardial depression are briefly discussed. ...
Sepsis and septic shock: pathophysiological and cardiovascular background as basis for therapy Ghent University KU Leuven
Early administration of Vitamin C in patients with sepsis or septic shock in emergency departments Vrije Universiteit Brussel University of Antwerp KU Leuven
BACKGROUND: Sepsis is a potentially life-threatening condition characterized by a deregulated body's response to infection causing injury to its own tissues and organs. Sepsis is the primary cause of death from infection. If not recognized and treated timely, it can evolve within minutes/hours to septic shock. Sepsis is associated with an acute deficiency of Vitamin C. Despite the proof-of-concept of the benefit of administering Vitamin C in ...
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock Vrije Universiteit Brussel
Introduction: Altered pharmacokinetics (PK) in critically ill patients can result in insufficient serum β-lactam concentrations when standard dosages are administered. Previous studies on β-lactam PK have generally excluded the most severely ill patients, or were conducted during the steady-state period of treatment. The aim of our study was to determine whether the first dose of piperacillin-tazobactam, ceftazidime, cefepime, and meropenem ...
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock Vrije Universiteit Brussel
Introduction: It has been proposed that doses of amikacin of >15 mg/kg should be used in conditions associated with an increased volume of distribution (Vd), such as severe sepsis and septic shock. The primary aim of this study was to determine whether 25 mg/kg (total body weight) of amikacin is an adequate loading dose for these patients.Methods: This was an open, prospective, multicenter study in four Belgian intensive care units (ICUs). ...
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies Ghent University
An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock Vrije Universiteit Brussel
RECENT FINDINGS: Despite positive signals from experimental, cases and small clinical studies, blood purification showed no distinct morbidity and mortality benefit in large clinical trials.
SUMMARY: None of the discussed specific membranes or cartridges can currently be recommended as sole adjunctive treatment in sepsis and septic shock. Any available technique should be timely initiated and adapted to the patient's status. Sickest ...